Artificial intelligence software that acts as a triage for breast cancer patients

Software that can determine which breast cancer patients are in the most urgent need of surgery or chemotherapy has been developed by British scientists. The artificial intelligence algorithm uses data from different studies to identify patients able to go on hormone therapy rather than require urgent surgery. Scientists created the technology as a way to ensure women get the best available treatment during the COVID-19 pandemic that has seen surgeries cancelled. It uses data from multiple international trials to pick out those whose tumours are less likely to respond to hormonal drugs and found 5 per cent were at the most risk. Software that can determine which breast cancer patients are in the most urgent need of surgery or chemotherapy has been developed by British scientists.